Nima Almassi

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer”.

HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

JAMA Oncology(2020)10.1001/jamaoncol.2019.6496

N/A

0DataRank · unranked

75 citations

Christopher J. Sweeney, Nima Almassi, Chad A. Reichard, C.A. Reddy, Hong Li +9 more

Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts

Nature Communications(2020)10.1038/s41467-020-15885-7

N/A

0DataRank · unranked

58 citations

Wenhuo Hu, François Audenet, Nima Almassi, Aphrothiti J. Hanrahan, Katie S. Murray +32 more

‘Case of the Month’ from Memorial Sloan Kettering Cancer Center, New York, NY, USA: managing newly diagnosed metastatic testicular germ cell tumour in a COVID‐19‐positive patient

British Journal of Urology(2020)10.1111/bju.15157

N/A

0DataRank · unranked

4 citations

John P. Mulhall, Samuel A. Funt, Joel Sheinfeld, Nima Almassi

Trends in management and outcomes in patients with upper tract urothelial carcinoma following radical nephrouretectomy at Memorial Sloan Kettering Cancer Center.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.469

N/A

0DataRank · unranked

2 citations

Melissa Assel, Andrew Tracey, Ricardo Alvim, Nima Almassi, Nirmish Singla +6 more

Association of radical cystectomy and increased risk of skeletal-related events in bone-metastatic urothelial carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.477

N/A

0DataRank · unranked

0 citations

Imaani Easthausen, Soleen Ghafoor, Paul J. Christos, Timothy F. Donahue, Jonathan E. Rosenberg +2 more

PD60-11 PROGNOSTIC SIGNIFICANCE OF PERIVESICAL LYMPH NODE STATUS IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER UNDERGOING RADICAL CYSTECTOMY

The Journal of Urology(2020)10.1097/ju.0000000000000977.011

N/A

0DataRank · unranked

0 citations

Melissa Assel, Cristina Falavolti, Chun Huang, Nima Almassi, Shawn Dason +10 more

MP55-17 IS UROTHELIAL CARCINOMA WITH SARCOMATOID DIFFERENTIATION RESPONSIVE TO NEOADJUVANT CHEMOTHERAPY?

The Journal of Urology(2020)10.1097/ju.0000000000000924.017

N/A

0DataRank · unranked

0 citations

Emily Vertosick, Daniel D. Sjoberg, Eugene J. Pietzak, Eugene Cha, Timothy F. Donahue +5 more

Pathological and oncological outcomes in patients with sarcomatoid differentiation undergoing cystectomy

British Journal of Urology(2021)10.1111/bju.15428

N/A

0DataRank · unranked

24 citations

Emily Vertosick, Daniel D. Sjoberg, Nathan C. Wong, Chun Huang, Eugene J. Pietzak +10 more

Genomic characterization of bladder cancer with variant histology.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.470

N/A

0DataRank · unranked

2 citations

Timothy N. Clinton, Wenhuo Hu, Nima Almassi, Peter A. Reisz, Hong Truong +12 more

Genomic heterogeneity as a barrier to precision oncology in urothelial cancer

Cell Reports(2022)10.1016/j.celrep.2022.111859

N/A

0DataRank · unranked

73 citations

Ziyu Chen, Hannah Wise, Andrew T. Lenis, Shweta S. Chavan, Mark T.A. Donoghue +20 more

Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1006

N/A

0DataRank · unranked

14 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.564

N/A

0DataRank · unranked

2 citations

Kwanghee Kim, Fengshen Kuo, Andrew T. Lenis, Jie‐Fu Chen, Wenhuo Hu +15 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Data from Inherited Germline Cancer Susceptibility Gene Variants in Individuals with Non–Muscle-Invasive Bladder Cancer

(2023)10.1158/1078-0432.c.6532764.v1

N/A

0DataRank · unranked

0 citations

Karissa Whiting, Preethi Srinivasan, Chaitanya Bandlamudi, Aliya Khurram, Vijai Joseph +26 more

Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma

European Urology(2024)10.1016/j.eururo.2024.10.024

N/A

0DataRank · unranked

9 citations

Syed M. Alam, Fengshen Kuo, Ziyu Chen, Wesley Yip, Andrew Katims +34 more

Single-cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathway

npj Precision Oncology(2025)10.1038/s41698-025-01093-3

N/A

0DataRank · unranked

4 citations

Emily E. Fink, Hong Qiu, Pierre-Emmanuel Desprez, Arvind Ravi, Mark Holton +9 more

Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing Therapy

Clinical Genitourinary Cancer(2025)10.1016/j.clgc.2025.102477

N/A

0DataRank · unranked

0 citations

Jessica Scarborough, C.A. Reddy, A. Bommireddy, Erin F. Brooks, Nima Almassi +12 more